NDC 85509-1202-06 - Naproxen and esomeprazole magnesium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 85509-1202
- Requested NDC
- 85509-1202-06
- Package NDCs from labels
- 85509-1202-3, 85509-1202-6, 85509-1202-06
- Manufacturer
- PHOENIX RX LLC
- Effective date
- 2025-07-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naproxen and esomeprazole magnesium - PHOENIX RX LLC | PHOENIX RX LLC | 2025-07-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85509-1202-3 | Naproxen and esomeprazole magnesium | 30 in 1 BOTTLE | TABLET, DELAYED RELEASE | 30 | 1 | |
| 85509-1202-6 | Naproxen and esomeprazole magnesium | 60 in 1 BOTTLE | TABLET, DELAYED RELEASE | 60 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 85509-1202-3 | EA - Each | 85509-1202 | 49443837-1ea1-40cc-9727-1156af2f2408 | 1 | 2025-09-12 |
| 85509-1202-6 | EA - Each | 85509-1202 | 5d7be8d3-1020-4270-b719-11ff4233bee9 | 1 | 2025-09-12 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | 6573681e-e9be-440f-a818-a533b744648e | 2026-11-09 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Eyewash Station Additive Concentrate | CHLORHEXIDINE GLUCONATE AND PROPYLENE GLYCOL | Encon Safety Products, Inc. | b5a62567-c9f1-0492-e053-2a95a90ab247 | 2026-11-05 | Warnings | 6DC9Q167V3 |
| Esomeprazole Magnesium | ESOMEPRAZOLE MAGNESIUM | PD-Rx Pharmaceuticals, Inc. | fdea1f5f-b717-4d49-8d70-0b373c959bf0 | 2026-11-02 | Warnings, Adverse reactions | R6DXU4WAY9 |
| Naproxen | NAPROXEN | REMEDYREPACK INC. | e519fa49-5bd9-405c-a7fb-1403edb8976b | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | REMEDYREPACK INC. | 12202ef3-c65e-45a6-88ed-5d945d8fd41c | 2026-10-28 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Mag 440 | MEGNESIUM OXIDE | Allegis Pharmaceuticals, LLC | 2cb19dc0-115b-38b8-e063-6294a90a4aea | 2026-10-26 | Warnings | 3A3U0GI71G |
| magnesium oxide | MAGNESIUM OXIDE | Marlex Pharmaceuticals Inc. | dc57893c-068a-37d8-e053-2a95a90aa054 | 2026-10-26 | Warnings | 3A3U0GI71G |
| Magnesium Oxide | MAGNESIUM OXIDE | Marlex Pharmaceuticals Inc | 0bb322a5-fb92-14de-e063-6294a90a4c1b | 2026-10-26 | Warnings | 3A3U0GI71G |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| PNV-Omega | ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM CORBONATE, FERROUS FUMARATE, POTASSIUM IODIDE, MAGNESIUM, DOCONEXENT, ICOSAPENT | Acella Pharmaceuticals, LLC | 735c5531-137f-4cee-8c68-ae121045a8ff | 2026-10-23 | Boxed warning, Adverse reactions | 3A3U0GI71G |
| Folivex | MULTIVITAMIN | Oncora Pharma, LLC | 98b4a821-c139-4e9b-99c7-6451af6c27ce | 2026-10-22 | Warnings, Adverse reactions | 3A3U0GI71G |
| Esomeprazole | ESOMEPRAZOLE MAGNESIUM | GERI-CARE PHARMACEUTICALS, CORP | 53a21928-8f5b-52c1-e063-6294a90add6c | 2026-10-20 | Warnings | R6DXU4WAY9 |
| Esomeprazole Magnesium | ESOMEPRAZOLE MAGNESIUM | REMEDYREPACK INC. | a02051ae-8e0c-4188-8a76-fcdf8b532a93 | 2026-10-16 | Warnings, Adverse reactions | R6DXU4WAY9 |
| Artificial Tears | GLYCERIN | Preferred Pharmaceuticals Inc. | dd646c72-8f47-43c6-a734-db0dcc8cd4d1 | 2026-10-14 | Warnings | 3NXW29V3WO |
| Naproxen | NAPROXEN | PD-Rx Pharmaceuticals, Inc. | 2d01e583-670a-46f4-b5f2-3fad46d0376f | 2026-10-14 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Esomeprazole | ESOMEPRAZOLE MAGNESIUM | HARRIS TEETER | ea9ef7b0-7397-470f-b852-397e8b0e66e4 | 2026-10-13 | Warnings | R6DXU4WAY9 |
| Rhinoost Smelling Salts | AMMONIA | Guangdong Jiaoyu Biotechnology Co., Ltd | 5d93a397-0528-b09d-e063-6394a90a5439 | 2026-10-11 | Warnings | 5138Q19F1X |
| Naproxen | NAPROXEN | A-S Medication Solutions | f856d3ff-7e70-4c5a-98fb-76d8af6adb46 | 2026-10-09 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | A-S Medication Solutions | d8726a3f-03d5-4a5a-a780-f760faaaecf3 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
| Naproxen | NAPROXEN | Granules Pharmaceuticals Inc. | c1cb9bb9-fbae-5e5c-e053-2995a90a0d21 | 2026-10-08 | Boxed warning, Warnings, Adverse reactions | 57Y76R9ATQ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.